18F-rhPSMA-7.3
Showing 1 - 25 of >10,000
Prostate Cancer Trial in Birmingham (18F-rhPSMA-7.3)
Not yet recruiting
- Prostate Cancer
- 18F-rhPSMA-7.3
-
Birmingham, AlabamaUAB
Jan 21, 2023
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Atlanta, Johns Creek (drug, other, procedure)
Not yet recruiting
- Prostate Adenocarcinoma
- Recurrent Prostate Carcinoma
- Furosemide
- +3 more
-
Atlanta, Georgia
- +3 more
Mar 9, 2023
Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8 Trial in Chicago (procedure,
Not yet recruiting
- Prostate Adenocarcinoma
- +3 more
- Biopsy of Prostate
- +6 more
-
Chicago, IllinoisNorthwestern University
May 9, 2023
Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Atlanta (procedure, radiation, other, drug)
Not yet recruiting
- Biochemically Recurrent Prostate Carcinoma
- Prostate Adenocarcinoma
- Biospecimen Collection
- +6 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Oct 25, 2023
Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma, Prostate Adenocarcinoma Trial in Houston (Fluorine F
Recruiting
- Biochemically Recurrent Prostate Carcinoma
- +2 more
- Fluorine F 18 rhPSMA-7.3
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Glen Burnie (177Lu-rhPSMA-10.1 injection,
Recruiting
- Prostate Cancer
- +5 more
- 177Lu-rhPSMA-10.1 injection
- 18F-rhPSMA-7.3 injection
-
Glen Burnie, Maryland
- +3 more
Feb 2, 2023
Prostate Cancer Trial in New York (18F-Labeled Positron Emission Tomography (PET) Diagnostic Agent, PET MRI Imaging)
Not yet recruiting
- Prostate Cancer
- 18F-Labeled Positron Emission Tomography (PET) Diagnostic Agent
- PET MRI Imaging
-
New York, New YorkSmilow Comprehensive Prostate Cancer Center
Jan 9, 2023
Prostate Cancer Trial in Bala-Cynwyd (rhPSMA-7.3 (18F))
Not yet recruiting
- Prostate Cancer
- rhPSMA-7.3 (18F)
-
Bala-Cynwyd, PennsylvaniaMidLantic Urology
Mar 22, 2023
Prostate Cancer Trial in Finland, Netherlands, United States (rhPSMA-7.3 (18F) Injection)
Completed
- Prostate Cancer
- rhPSMA-7.3 (18F) Injection
-
Birmingham, Alabama
- +27 more
Mar 15, 2022
Prostate Cancer Trial in Worldwide (rhPSMA-7.3 (18F) Injection)
Completed
- Prostate Cancer
- rhPSMA-7.3 (18F) Injection
-
Birmingham, Alabama
- +33 more
Mar 15, 2022
Prostate Cancer Trial in Turku (rhPSMA-7.3 (18F) Injection)
Completed
- Prostate Cancer
- rhPSMA-7.3 (18F) Injection
-
Turku, FinlandClinical Research Services Turku - CRST Oy
May 15, 2020
Prostate Cancer, 18F- Fluorocholine, PSMA PET Trial (Radiopharmaceutical 18F-JK-PSMA-7, Radiopharmaceutical 18F-Fluorocholine)
Not yet recruiting
- Prostate Cancer
- +5 more
- Radiopharmaceutical 18F-JK-PSMA-7
- Radiopharmaceutical 18F-Fluorocholine
- (no location specified)
Nov 17, 2022
Breast Cancer, Breast Tumor Trial in Philadelphia ([18F]ISO-1)
Active, not recruiting
- Breast Cancer
- Breast Neoplasm
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Hospital
Jan 17, 2023
Cerebral Gliosis, Positron Emission Tomography Trial in Shanghai ([18F]BF3-BPA Injection for PET Imaging)
Recruiting
- Cerebral Gliosis
- Positron Emission Tomography
- [18F]BF3-BPA Injection for PET Imaging
-
Shanghai, ChinaHuashan Hospital
Nov 19, 2023
Brain Metastases, Brain Metastases, Adult, Brain Cancer Trial in Miami (18F fluciclovine)
Not yet recruiting
- Brain Metastases
- +2 more
- 18F fluciclovine
-
Miami, FloridaMiami Cancer Institute
Sep 15, 2023
Clear Cell Sarcoma of Soft Tissue Trial in Wuhan (18F-PFPN)
Recruiting
- Clear Cell Sarcoma of Soft Tissue
-
Wuhan, Hubei, ChinaChina, Hubei Province
Jul 19, 2023
Renal Tumor Trial
Not yet recruiting
- Renal Tumor
- (no location specified)
Aug 2, 2023
Breast Tumors Trial
Not yet recruiting
- Breast Tumors
- (no location specified)
Aug 2, 2023
Tumors Trial in Chengdu
Recruiting
- Neoplasms
-
Chengdu, Sichuan, ChinaDepartments of Nuclear Medicine, Sichuan Provincial People's Hos
Oct 16, 2023
Rheumatoid Arthritis Trial
Not yet recruiting
- Rheumatoid Arthritis
- (no location specified)
Jul 6, 2023
Prostate Cancer Trial in Edmonton (PSMA-1007 Positron Emission Tomography (PET) scan and 3T Magnetic Resonance Imaging (MRI))
Recruiting
- Prostate Cancer
- PSMA-1007 Positron Emission Tomography (PET) scan and 3T Magnetic Resonance Imaging (MRI)
-
Edmonton, Alberta, CanadaUniversity of Alberta
Jan 9, 2023
Amyloid, Amyloid Cardiomyopathy Trial in Pisa (18F-florbetaben PET/CT)
Recruiting
- Amyloid
- Amyloid Cardiomyopathy
- 18F-florbetaben PET/CT
-
Pisa, ItalyFondazione Toscana Gabriele Monasterio
Sep 16, 2023
SSTR2, FAP, Positron-Emission Tomography Trial in Xiamen (18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT)
Recruiting
- SSTR2
- +2 more
- 18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT
-
Xiamen, Fujian, ChinaThe First Affiliated Hospital of Xiamen University
May 24, 2023